The Indian Immunologicals Limited (IIL), a leading vaccine manufacturer, donated a Pressure Swing Adsorption (PSA) Oxygen Generation Plant to the Telangana Institute of Medical Sciences (TIMS), Gachibowli, for service to patients in need of oxygen support. The plant is capable of supplying oxygen to 70 patients simultaneously. The IIL had taken up this initiative at a cost of Rs 1 crore as part of their CSR and executed it through Sambhav Foundation, an initiative of LabourNet, a Bengaluru-based social enterprise.
Speaking on the occasion, Dr Vimala Thomas, Director, TIMS, had thanked IIL for this timely support. Dr Vimala Thomas had mentioned that with this installation, TIMS is significantly equipped to treat the patients in need of oxygen support, specifically those suffering from Covid-related complications. Dr K Anand Kumar, Managing Director, IIL, Dr Priyabrata Pattnaik, Deputy Managing Director, IIL and others were present on the occasion.
Indian Immunologicals Limited or IIL is a biopharmaceutical company based in Hyderabad, Telangana, India. IIL is one of the largest vaccine manufacturers in the world. It was established in 1982 by the National Dairy Development Board. It is noted for developing veterinary and human vaccines for foot-and-mouth disease, rabies, bacterial vaccines, canine vaccines, hepatitis, measles, MMR and DPT.